{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:55:43Z","timestamp":1779173743975,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"crossref","award":["AID-OAA-A-14-00012"],"award-info":[{"award-number":["AID-OAA-A-14-00012"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10461-021-03434-2","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T14:15:41Z","timestamp":1632233741000},"page":"752-763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5477-4445","authenticated-orcid":false,"given":"Elizabeth T.","family":"Montgomery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah T.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnaveni","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Tolley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Mathebula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Danielle","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth","family":"Zissette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Lanham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Wilcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared M.","family":"Baeten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thesla","family":"Palanee-Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"3434_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1874613601610010034","volume":"10","author":"AB Kharsany","year":"2016","unstructured":"Kharsany AB, Karim QA. HIV infection and AIDS in sub-Saharan Africa: current status, challenges and opportunities. The open AIDS journal. 2016;10:34.","journal-title":"The open AIDS journal"},{"key":"3434_CR2","doi-asserted-by":"crossref","unstructured":"Ackermann, L. and G.W.d. Klerk, Social factors that make South African women vulnerable to HIV infection. Health care for women international, 2002. 23(2): p. 163\u2013172.","DOI":"10.1080\/073993302753429031"},{"issue":"9419","key":"3434_CR3","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(04)16098-4","volume":"363","author":"KL Dunkle","year":"2004","unstructured":"Dunkle KL, et al. Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. The lancet. 2004;363(9419):1415\u201321.","journal-title":"The lancet"},{"issue":"9734","key":"3434_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0140-6736(10)60548-X","volume":"376","author":"RK Jewkes","year":"2010","unstructured":"Jewkes RK, et al. Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study. The lancet. 2010;376(9734):41\u20138.","journal-title":"The lancet"},{"issue":"Suppl 2","key":"3434_CR5","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1097\/01.aids.0000327435.28538.18","volume":"22","author":"A Greig","year":"2008","unstructured":"Greig A, et al. Gender and AIDS: time to act. AIDS (London, England). 2008;22(Suppl 2):S35.","journal-title":"AIDS (London, England)"},{"issue":"5","key":"3434_CR6","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s10461-019-02707-1","volume":"24","author":"ST Roberts","year":"2020","unstructured":"Roberts ST, et al. Impact of male partner involvement on women\u2019s adherence to the dapivirine vaginal ring during a phase III HIV prevention trial. AIDS Behav. 2020;24(5):1432\u201342.","journal-title":"AIDS Behav"},{"key":"3434_CR7","unstructured":"MTN, Monthly vaginal ring advances toward potential approval as new HIV prevention method for women, in Positive opinion by European Medicines Agency paves way for IPM to pursue approvals of dapivirine ring in African countries. 2020: Pittsburgh, PA."},{"issue":"22","key":"3434_CR8","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","volume":"375","author":"A Nel","year":"2016","unstructured":"Nel A, et al. Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J Med. 2016;375(22):2133\u201343.","journal-title":"N Engl J Med"},{"issue":"22","key":"3434_CR9","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375(22):2121\u201332.","journal-title":"N Engl J Med"},{"key":"3434_CR10","unstructured":"Agency, E.M., Dapivirine Vaginal Ring 25 mg H-W-2168: Summary of Product Characteristics 2020, [in publication]."},{"key":"3434_CR11","unstructured":"Roberts, S.T., et al., Impact of Male Partner Involvement on Women\u2019s Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial. AIDS and Behavior, 2019: p. 1\u201311."},{"key":"3434_CR12","doi-asserted-by":"crossref","unstructured":"Palanee-Phillips, T., et al., Impact of partner-related social harms on women's adherence to the dapivirine vaginal ring during a phase III trial. J Acquir Immune Defic Syndr, 2018.","DOI":"10.1097\/QAI.0000000000001866"},{"key":"3434_CR13","unstructured":"Baeten, J. High adherence and sustained impact on HIV-1 incidence: Final results of an open-label extension trial of the dapivirine vaginal ring. in IAS 2010. 2019. Mexico City, Mexico."},{"issue":"5","key":"3434_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1521\/aeap.2019.31.5.433","volume":"31","author":"M Hartmann","year":"2019","unstructured":"Hartmann M, et al. Generating CHARISMA: development of an intervention to help women build agency and safety in their relationships while using PrEP for HIV Prevention. AIDS Educ Prev. 2019;31(5):433\u201351.","journal-title":"AIDS Educ Prev"},{"issue":"1","key":"3434_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12905-021-01262-z","volume":"21","author":"EK Wilson","year":"2021","unstructured":"Wilson EK, et al. Acceptability and feasibility of the CHARISMA counseling intervention to support women\u2019s use of pre-exposure prophylaxis: results of a pilot study. BMC Womens Health. 2021;21(1):126.","journal-title":"BMC Womens Health"},{"issue":"2","key":"3434_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10461-020-03011-z","volume":"25","author":"IC Bal\u00e1n","year":"2021","unstructured":"Bal\u00e1n IC, et al. Client-centered adherence counseling with adherence measurement feedback to support use of the dapivirine ring in MTN-025 (The HOPE Study). AIDS Behav. 2021;25(2):447\u201358.","journal-title":"AIDS Behav"},{"issue":"1","key":"3434_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1186\/s12913-016-1872-x","volume":"16","author":"C Pallitto","year":"2016","unstructured":"Pallitto C, et al. Testing a counselling intervention in antenatal care for women experiencing partner violence: a study protocol for a randomized controlled trial in Johannesburg, South Africa. BMC Health Serv Res. 2016;16(1):630.","journal-title":"BMC Health Serv Res"},{"issue":"9543","key":"3434_CR18","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(06)69523-8","volume":"368","author":"C Garcia-Moreno","year":"2006","unstructured":"Garcia-Moreno C, et al. Prevalence of intimate partner violence: findings from the WHO multi-country study on women\u2019s health and domestic violence. Lancet. 2006;368(9543):1260\u20139.","journal-title":"Lancet"},{"key":"3434_CR19","unstructured":"Brown, E., et al., Residual dapivirine ring levels indicate higher adherence to vaginal ring is associated with HIV-1 protection, in IAS. 2016: Durban."},{"key":"3434_CR20","unstructured":"Team, T.M.-A.S. A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Prevention in Women. in CROI 2016. 2016. Boston, USA."},{"issue":"10","key":"3434_CR21","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.socscimed.2009.08.014","volume":"69","author":"NN Sahin-Hodoglugil","year":"2009","unstructured":"Sahin-Hodoglugil NN, et al. Degrees of disclosure: a study of women\u2019s covert use of the diaphragm in an HIV prevention trial in sub-Saharan Africa. Soc Sci Med. 2009;69(10):1547\u201355.","journal-title":"Soc Sci Med"},{"issue":"3 Suppl 2","key":"3434_CR22","doi-asserted-by":"crossref","first-page":"19159","DOI":"10.7448\/IAS.17.3.19159","volume":"17","author":"M Lanham","year":"2014","unstructured":"Lanham M, et al. Engaging male partners in women\u2019s microbicide use: evidence from clinical trials and implications for future research and microbicide introduction. J Int AIDS Soc. 2014;17(3 Suppl 2):19159.","journal-title":"J Int AIDS Soc"},{"issue":"8893","key":"3434_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0140-6736(94)91205-X","volume":"343","author":"ZA Stein","year":"1994","unstructured":"Stein ZA. Vaginal microbicides and prevention of HIV infection. Lancet. 1994;343(8893):362\u20133.","journal-title":"Lancet"},{"key":"3434_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s10461-010-9806-9","volume":"15","author":"ET Montgomery","year":"2010","unstructured":"Montgomery ET, et al. The importance of male partner involvement for women\u2019s acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe. AIDS Behav. 2010;15:959\u201369. https:\/\/doi.org\/10.1007\/s10461-010-9806-9.","journal-title":"AIDS Behav"},{"issue":"11","key":"3434_CR25","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1007\/s10461-016-1339-4","volume":"20","author":"KM MacQueen","year":"2016","unstructured":"MacQueen KM, et al. Social context of adherence in an open-label 1 % tenofovir gel trial: gender dynamics and disclosure in KwaZulu-Natal South Africa. AIDS Behav. 2016;20(11):2682\u201391.","journal-title":"AIDS Behav"},{"issue":"5","key":"3434_CR26","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1097\/QAI.0b013e31821d33d6","volume":"57","author":"E Montgomery","year":"2011","unstructured":"Montgomery E, van der Straten A, Torjesen K. \u201cMale involvement\u201d in women and children\u2019s HIV prevention: challenges in definition and interpretation. J Acquir Immune Defic Syndr. 2011;57(5):e114\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3434_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1758-2652-13-30","volume":"13","author":"ET Montgomery","year":"2010","unstructured":"Montgomery ET, et al. An acceptability and safety study of the Duet cervical barrier and gel delivery system in Zimbabwe. J Int AIDS Soc. 2010;13:30.","journal-title":"J Int AIDS Soc"},{"key":"3434_CR28","unstructured":"Montgomery, E., et al., Involving male partners in trials of female-initiated HIV prevention methods in Africa: A review of strategies and evidence, in 5th IAS Conference on HIV Pathogenesis, Treatment & Prevention,. 2009: Cape Town, South Africa."},{"key":"3434_CR29","unstructured":"Montgomery, E.T., et al., Male Partner Influence on Women\u2019s HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of \u201cUnderstanding\u201d. AIDS and Behavior, 2014: p. 1\u201310."},{"issue":"6","key":"3434_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/09540120701693974","volume":"20","author":"CM Montgomery","year":"2008","unstructured":"Montgomery CM. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care. 2008;20(6):733\u201340.","journal-title":"AIDS Care"},{"key":"3434_CR31","unstructured":"Wilson, E., et al., Acceptability and feasibility of CHARISMA: Results of a pilot study addressing relationship dynamics, intimate partner violence and microbicide use. , in HIV Research for Prevention 2018: Madrid, Spain."},{"issue":"14","key":"3434_CR32","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1097\/QAD.0000000000002346","volume":"33","author":"ET Montgomery","year":"2019","unstructured":"Montgomery ET, et al. Social harms in female-initiated HIV prevention method research: state of the evidence. AIDS. 2019;33(14):2237\u201344.","journal-title":"AIDS"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03434-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-021-03434-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03434-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T04:31:52Z","timestamp":1699504312000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-021-03434-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["3434"],"URL":"https:\/\/doi.org\/10.1007\/s10461-021-03434-2","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,21]]},"assertion":[{"value":"10 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Review Boards at RTI International, all study sites, and was overseen by the regulatory infrastructure of the US National Institutes of Health and the Microbicide Trials Network.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All study participants provided written informed consent to participate in the study through a consent process approved by local ethical review committees in all research settings.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All participants were informed that any publication of this study will not use their name or identify them personally.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}